Apoe
-/-and DKO mice were fed a high fat-high cholesterol (HCHF) diet for 12 weeks with or without ETC-1002 to achieve a 30 mg/kg/day dose. (A) Body mass (B) Adiposity, and (C) lean mass determined at sacrifice (n = 15 for Apoe -/-, and n = 11 for control DKO, and n = 12 for ETC-1002 treated DKO). Fasting (D) glucose and (E) insulin were determined at 10 weeks on diet (glucose; n = 15 for Apoe -/-, and n = 11 for control DKO, and n = 12 for ETC-1002 treated DKO; and insulin n = 6/group). Glucose tolerance test (GTT) was performed in (F) Apoe -/-and (G) DKO mice and (H) AUC (0 -120 min.) calculated. (I) Effects of HFHC diet on Srebf2, Ldlr, Pcsk9, Hmgr, Acly, Srebf1 , and Slc27a2 gene expression normalized to chow-fed mice was (n= 4 chow-fed and n = 5 for remaining treatment groups) determined at the end of study. Multiple comparisons were made using (I) unpaired Student's t-test or an *one-way (within Apoe -/-treatment groups) or # two-way ANOVA (between Apoe -/-and DKO treatment groups); Bonferroni's multiple comparisons test; * p < 0.05.
Supplementary Figure 7. ETC-1002 is inactive in bone-marrow derived macrophages.
Hematopoietic stem cells were isolated from WT and β1 KO mice by taking the tibia and femur from both legs of one mouse and spinning out the bone marrow for 5 min at 4500 rpm in DMEM containing 4.5 g/L glucose, sodium pyruvate (110mg/L), 10% (v/v) fetal bovine serum, 100 IU/ml penicillin, 100 μg/ml streptomycin. The following day, the stem cells were stimulated to differentiate into BMDM under L929. (A) Following 8 days of differentiation, Slc27a2 and β-actin expression was measured and compared to liver expression (n = 6). (B) Phosphorylation of ACC was measured in BMDM treated with Vehicle, ETC-1002 (30 and 100 µM), or A-769662 (100 µM). ETC-1002 did not increase ACC phosphorylation. (C) ETC-1002 did not lower lipogenesis in WT or β1 KO. Two-way ANOVA was used to detect statistical differences. n = 3-8 performed in triplicate measures. Data are expressed as mean ± SEM. *P < 0.05, significantly different from control.
